|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
OrthoCyte Corporation
| | | Phone: | (510) 775-0451 | Year Established: | 2006 | Ticker: | BTX | Exchange: | OTCBB | Main Contact: | Francois Binette , Ph.D., Head of Global Development | | Other Contacts: | Michael D. West, Ph.D., CEO
| |
| Company Description | OrthoCyte, acquired by BioTime company, is a leader in developing, manufacturing, and marketing proprietary biocompatible hydrogels that mimic the extracellular matrix (ECM). The ECM is an important and complex mixture of macromolecules that holds cells together in tissues and organs and performs many other important functions. OrthoCyte's products have the demonstrated ability to support the growth and directed differentiation of stem cells and are designed as implantable, resorbable matrices for tissue engineering, regenerative medicine, and for research applications involving the laboratory culture of human cells. | |
|
|
|
|
|